|
KIAA0090 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.521600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.671900E-02 |
| Normal-vs-Stage2 |
5.482800E-01 |
| Normal-vs-Stage3 |
1.591850E-02 |
| Normal-vs-Stage4 |
2.902100E-02 |
| Stage1-vs-Stage2 |
3.468800E-01 |
| Stage1-vs-Stage3 |
3.643000E-01 |
| Stage1-vs-Stage4 |
4.778400E-01 |
| Stage2-vs-Stage3 |
1.260640E-01 |
| Stage2-vs-Stage4 |
1.726780E-01 |
| Stage3-vs-Stage4 |
9.806000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.138100E-02 |
| Normal-vs-AfricanAmerican |
8.981000E-01 |
| Normal-vs-Asian |
1.454050E-02 |
| Caucasian-vs-AfricanAmerican |
1.585160E-01 |
| Caucasian-vs-Asian |
2.749400E-01 |
| AfricanAmerican-vs-Asian |
3.257900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.345890E-02 |
| Normal-vs-Female |
8.910500E-02 |
| Male-vs-Female |
1.714370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.617600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.502000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.818000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.653040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.904400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.321200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.966800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.082200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.574600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.417000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.856390E-03 |
| Classical-VS-Follicular |
2.677600E-02 |
| Classical-VS-Other |
1.959650E-02 |
| Classical-VS-Normal |
2.974800E-01 |
| Tall-VS-Follicular |
2.936200E-01 |
| Tall-VS-Other |
1.576590E-01 |
| Tall-VS-Normal |
2.457800E-03 |
| Follicular-VS-Other |
1.355640E-01 |
| Follicular-VS-Normal |
1.689810E-02 |
| Other-VS-Normal |
5.699300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.315600E-02 |
| Normal-vs-N1 |
7.337000E-03 |
| N0-vs-N1 |
1.373620E-01 |
|
|
